These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29271734)

  • 1. Pharmacological properties of oral antibiotics for the treatment of uncomplicated urinary tract infections.
    Novelli A; Rosi E
    J Chemother; 2017 Dec; 29(sup1):10-18. PubMed ID: 29271734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why not performing susceptibility test for trimethoprim-sulphamethoxazole?
    Hagiya H
    J Chemother; 2015 Feb; 27(2):124-5. PubMed ID: 25248022
    [No Abstract]   [Full Text] [Related]  

  • 3. Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
    Bedenic B; Topic M; Budimir A; Bubonja M
    Chemotherapy; 2006; 52(6):293-7. PubMed ID: 17008781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections.
    Patel SS; Balfour JA; Bryson HM
    Drugs; 1997 Apr; 53(4):637-56. PubMed ID: 9098664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of plasmid-mediated resistance genes among multidrug-resistant uropathogens in Egypt.
    Elshamy AA; Aboshanab KM; Yassien MA; Hassouna NA
    Afr Health Sci; 2020 Mar; 20(1):190-198. PubMed ID: 33402907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of fosfomycin tromethamine against extended spectrum beta-lactamase producing urinary tract bacteria.
    Khan IU; Mirza IA; Ikram A; Ali S; Hussain A; Ghafoor T
    J Coll Physicians Surg Pak; 2014 Dec; 24(12):914-7. PubMed ID: 25523727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections.
    Concia E; Bragantini D; Mazzaferri F
    J Chemother; 2017 Dec; 29(sup1):19-28. PubMed ID: 29271735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resistance of causative agents of uncomplicated urinary tract infections in Russia].
    Rafal'skiĭ VV; Strachunskiĭ LS; Babkin PA; Valenskaia VS; Gabbasova LA; Dmitrieva OB; Emel'ianova IV; Krupin VN; Malev IV; Petrov SB; Rokhlikov IM; Furletova NM; Khaĭrullov AS
    Urologiia; 2006; (5):34-7. PubMed ID: 17444150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of bacterial urinary tract infections: presence and future.
    Wagenlehner FM; Naber KG
    Eur Urol; 2006 Feb; 49(2):235-44. PubMed ID: 16413668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility pattern of bacteria isolated from patients with urinary tract infection.
    Khan IU; Mirza IA; Ikram A; Afzal A; Ali S; Hussain A; Fayyaz M; Ghafoor T
    J Coll Physicians Surg Pak; 2014 Nov; 24(11):840-4. PubMed ID: 25404444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar.
    Randrianirina F; Soares JL; Carod JF; Ratsima E; Thonnier V; Combe P; Grosjean P; Talarmin A
    J Antimicrob Chemother; 2007 Feb; 59(2):309-12. PubMed ID: 17138569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of uncomplicated lower urinary tract infections].
    Horcajada JP; García-Palomo D; Fariñas MC
    Enferm Infecc Microbiol Clin; 2005 Dec; 23 Suppl 4():22-7. PubMed ID: 16854355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methenamine: a forgotten drug for preventing recurrent urinary tract infection in a multidrug resistance era.
    Lo TS; Hammer KD; Zegarra M; Cho WC
    Expert Rev Anti Infect Ther; 2014 May; 12(5):549-54. PubMed ID: 24689705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic susceptibility of bacteria isolated from infections in cats and dogs throughout Europe (2002-2009).
    Kroemer S; El Garch F; Galland D; Petit JL; Woehrle F; Boulouis HJ
    Comp Immunol Microbiol Infect Dis; 2014 Mar; 37(2):97-108. PubMed ID: 24447508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review.
    Mazzariol A; Bazaj A; Cornaglia G
    J Chemother; 2017 Dec; 29(sup1):2-9. PubMed ID: 29271736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study.
    García-Rodríguez JA; Trujillano Martín I; Baquero F; Cisterna R; Gobernado M; Liñares F; Martín-Luengo F; Piédrola G
    J Chemother; 1997 Dec; 9(6):394-402. PubMed ID: 9491838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Etiologic factors in urinary tract infection investigated in ambulatory setting. Community-acquired urinary tract infection: etiologic aspects and antibiotic resistance].
    Al Haddad C; Graure M; Grigore L; Niţescu R; Năşcuţiu AM; Ionescu G
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(1):17-22. PubMed ID: 20524391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
    Farajnia S; Alikhani MY; Ghotaslou R; Naghili B; Nakhlband A
    Int J Infect Dis; 2009 Mar; 13(2):140-4. PubMed ID: 18703368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of the susceptibility of urinary isolates to antibacterial agents in 2003.
    Ishikawa K; Hayakawa S; Miyakawa S; Kusaka M; Shiroki R; Hoshinaga K
    J Infect Chemother; 2005 Feb; 11(1):44-7. PubMed ID: 15729488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.